Sell Saxenda directly after non-face-to-face treatment?
By Jung, Heung-Jun | translator Choi HeeYoung
22.07.08 06:00:09
Some hospitals, direct sales to patients
Pharmacists concern over misuse
Can hospitals sell Saxenda, known as diet injections, directly to patients after non-face-to-face treatment? It is an expensive drug worth more than 100,000 won per unit and there is a high demand for purchase, so it is not prescribed for outpatients. The problem is that some hospitals sell and deliver directly to patients even in non-face-to-face treatment. On blogs, people can find reviews of prescriptions that seem to have received Saxenda directly from the hospital. Pharmacists have increased their outpatient prescriptions since the controversy over abuse of Saxenda in the past, and it is pointed out that it is inappropriate to use non-face-to-face treatment to administer inpatients Rx.
Pharmacist A
Jung, Heung-Jun(jhj@dailypharm.com)